The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer.

Tumor metastasis is an important clinical problem, contributing to the majority of cancer-related deaths. The recent discovery of metastasis suppressor genes, such as N-myc downstream-regulated gene-1 (Ndrg-1), has introduced a novel approach to treating cancer and preventing metastasis. Ndrg-1 has been identified as a protein involved in the differentiation of epithelial cells. In addition, Ndrg-1 expression can be regulated by androgens and is involved in the pathology of the disease, Hereditary Motor and Sensory Neuropathy-Lom (HMSNL). However, one of the most well documented links between Ndrg-1 and pathophysiology is its association with inhibition of tumor metastasis. The expression of Ndrg-1 was found to be significantly downregulated in a variety of different neoplasms including breast, colon and prostate cancer. Furthermore, Ndrg-1 expression was shown to be negatively correlated with tumor metastasis. Studies in vitro and in vivo have demonstrated a significant reduction in the metastatic ability of cells overexpressing Ndrg-1. The ability of these cells to invade was also compromised. The Gleason grade of prostate and breast cancers was found to correlate with Ndrg-1 expression, with more advanced and poorly differentiated tumors having lower Ndrg-1 levels. Recently, Ndrg-1 expression was demonstrated to be regulated by cellular iron levels and induced by iron chelators. These latter compounds were recently identified as potential anticancer agents as they selectively prevent cancer cell proliferation and lead to apoptosis. The discovery that iron chelators also increase Ndrg-1 expression further augments their antitumor activity and provides a novel strategy for the treatment of cancer and its metastasis.

[1]  M. M. Rees,et al.  Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. , 1993, Thrombosis research.

[2]  N. Imamoto,et al.  The 70-kD heat shock cognate protein (hsc70) facilitates the nuclear export of the import receptors , 2005, The Journal of cell biology.

[3]  Yun-Fai Chris Lau,et al.  Unopposed c‐MYC expression in benign prostatic epithelium causes a cancer phenotype , 2005, The Prostate.

[4]  J. Folkman.  Tumor angiogensis: role in regulation of tumor growth. , 1974, The ... Symposium. Society for Developmental Biology. Symposium.

[5]  Yusuke Nakamura,et al.  Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway , 2001, Oncogene.

[6]  M. Kuwano,et al.  Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. , 2006, Cancer research.

[7]  P K Thomas,et al.  N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. , 2000, American journal of human genetics.

[8]  G. Schwartz,et al.  Advances in Brief Drg 1 , a Novel Target for Modulating Sensitivity to CPT-11 in Colon Cancer Cells 1 , 2002 .

[9]  D. Richardson,et al.  Potent Antitumor Activity of Novel Iron Chelators Derived from Di-2-Pyridylketone Isonicotinoyl Hydrazone Involves Fenton-Derived Free Radical Generation , 2004, Clinical Cancer Research.

[10]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[11]  M. Yamaguchi,et al.  17β-Estradiol Induces Down-Regulation of Cap43/NDRG1/Drg-1, a Putative Differentiation-Related and Metastasis Suppressor Gene, in Human Breast Cancer Cells , 2006, Clinical Cancer Research.

[12]  T. Miyata,et al.  Ndrg1-Deficient Mice Exhibit a Progressive Demyelinating Disorder of Peripheral Nerves , 2004, Molecular and Cellular Biology.

[13]  Ying Wang,et al.  PTEN Up-Regulates the Tumor Metastasis Suppressor Gene Drg-1 in Prostate and Breast Cancer , 2004, Cancer Research.

[14]  D. Richardson,et al.  The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells. , 1997, Biochimica et biophysica acta.

[15]  K. Hunter,et al.  A new member of the growing family of metastasis suppressors identified in prostate cancer. , 2003, Journal of the National Cancer Institute.

[16]  D. Richardson,et al.  The effect of potent iron chelators on the regulation of p53: examination of the expression, localization and DNA-binding activity of p53 and the transactivation of WAF1. , 2003, Carcinogenesis.

[17]  D. Welch,et al.  Implications of tumor progression on clinical oncology , 1985, Clinical & Experimental Metastasis.

[18]  J. Caro,et al.  Hypoxia regulation of gene transcription. , 2001, High altitude medicine & biology.

[19]  G. Schwartz,et al.  Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells. , 2002, Cancer research.

[20]  M. Blagosklonny,et al.  Carcinogenic nickel induces genes involved with hypoxic stress. , 2000, Cancer research.

[21]  J. Swinnen,et al.  The differentiation‐related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells , 1999, FEBS letters.

[22]  M. Murakami,et al.  Association of N-myc downregulated gene 1 with heat-shock cognate protein 70 in mast cells. , 2004, Biological & pharmaceutical bulletin.

[23]  T. Werner,et al.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. , 1995, Nucleic acids research.

[24]  H. Kondoh,et al.  N-myc-dependent repression of Ndr1, a gene identified by direct subtraction of whole mouse embryo cDNAs between wild type and N-myc mutant , 1999, Mechanisms of Development.

[25]  F. Bosman,et al.  Expression of NDRG1, a differentiation-related gene, in human tissues , 2002, Histochemistry and Cell Biology.

[26]  D. Richardson.  Molecular mechanisms of iron uptake by cells and the use of iron chelators for the treatment of cancer. , 2005, Current medicinal chemistry.

[27]  C. Bucana,et al.  Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  D. Polsky,et al.  Altered N-myc Downstream-Regulated Gene 1 Protein Expression in African-American Compared with Caucasian Prostate Cancer Patients , 2004, Clinical Cancer Research.

[29]  W. Gardner,et al.  Carcinogenesis , 1961, The Yale Journal of Biology and Medicine.

[30]  Y. Sadovsky,et al.  N-Myc Down-regulated Gene 1 Modulates the Response of Term Human Trophoblasts to Hypoxic Injury* , 2006, Journal of Biological Chemistry.

[31]  T. Lin,et al.  Cloning and characterization of TDD5, an androgen target gene that is differentially repressed by testosterone and dihydrotestosterone. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[32]  I. Ninomiya,et al.  Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects. , 2004, International journal of oncology.

[33]  M. Fritsche,et al.  Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. , 1993, Oncogene.

[34]  Y. Yoneda,et al.  A Nuclear Localization Signal of Human Aryl Hydrocarbon Receptor Nuclear Translocator/Hypoxia-inducible Factor 1β Is a Novel Bipartite Type Recognized by the Two Components of Nuclear Pore-targeting Complex* , 1997, The Journal of Biological Chemistry.

[35]  K. Salnikow,et al.  Cap43, a novel gene specifically induced by Ni2+ compounds. , 1998, Cancer research.

[36]  G. Watts,et al.  NDRG1 interacts with APO A-I and A-II and is a functional candidate for the HDL-C QTL on 8q24. , 2005, Biochemical and biophysical research communications.

[37]  D. Richardson,et al.  Novel di-2-pyridyl-derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment. , 2004, Blood.

[38]  Yehia Mechref,et al.  Modulation of Differentiation-related Gene 1 Expression by Cell Cycle Blocker Mimosine, Revealed by Proteomic Analysis* , 2005, Molecular & Cellular Proteomics.

[39]  K. Kulp,et al.  Mimosine blocks cell cycle progression by chelating iron in asynchronous human breast cancer cells. , 1996, Toxicology and applied pharmacology.

[40]  G. Semenza,et al.  Up‐regulation of gene expression by hypoxia is mediated predominantly by hypoxia‐inducible factor 1 (HIF‐1) , 2005, The Journal of pathology.

[41]  S. Aaronson,et al.  Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. , 1998, Cancer research.

[42]  D. Boldt.  New perspectives on iron: an introduction. , 1999, The American journal of the medical sciences.

[43]  M. Murakami,et al.  N-myc downregulated gene 1 is a phosphorylated protein in mast cells. , 2004, Biological & pharmaceutical bulletin.

[44]  K. Agarwala,et al.  Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein. , 2000, Biochemical and biophysical research communications.

[45]  T. Moon,et al.  Identification of NDRG1 as an early inducible gene during in vitro maturation of cultured mast cells. , 2003, Biochemical and biophysical research communications.

[46]  D. Richardson,et al.  Identification of the di‐pyridyl ketone isonicotinoyl hydrazone (PKIH) analogues as potent iron chelators and anti‐tumour agents , 2003, British journal of pharmacology.

[47]  C. Lawrence,et al.  Identification of a novel class in the alpha/beta hydrolase fold superfamily: the N-myc differentiation-related proteins. , 2002, Proteins.

[48]  R Tibshirani,et al.  Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification , 2006, Oncogene.

[49]  K. Salnikow,et al.  Cap 43 , a Novel Gene Specifically Induced by Ni 2 + Compounds 1 , 2006 .

[50]  H. Ford,et al.  Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. , 2000, Cancer research.

[51]  M. Ivan,et al.  HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing , 2001, Science.

[52]  T. Miyata,et al.  Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. , 2001, Genomics.

[53]  D. Welch,et al.  Metastasis suppressor pathways--an evolving paradigm. , 2003, Cancer letters.

[54]  Fuchu He,et al.  Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family , 2004, Molecular and Cellular Biochemistry.

[55]  D. Richardson,et al.  The Evolution of Iron Chelators for the Treatment of Iron Overload Disease and Cancer , 2005, Pharmacological Reviews.

[56]  Qiangao,et al.  Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm , 2004 .

[57]  P. Reichard,et al.  Iron and free radical in ribonucleotide reductase. Exchange of iron and Mössbauer spectroscopy of the protein B2 subunit of the Escherichia coli enzyme. , 1973, The Journal of biological chemistry.

[58]  M. Westfall,et al.  NDRG1 Is Necessary for p53-dependent Apoptosis* , 2004, Journal of Biological Chemistry.

[59]  M. Henriksson,et al.  Proteins of the Myc network: essential regulators of cell growth and differentiation. , 1996, Advances in cancer research.

[60]  T. Commes,et al.  Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. , 1999, Biochimica et biophysica acta.

[61]  L. McCue,et al.  Identification of a novel class in the α/β hydrolase fold superfamily: The N‐myc differentiation‐related proteins , 2002 .

[62]  K. Miura,et al.  The Drg-1 gene suppresses tumor metastasis in prostate cancer. , 2003, Cancer research.

[63]  T. Miyata,et al.  Homocysteine-respondent Genes in Vascular Endothelial Cells Identified by Differential Display Analysis , 1996, The Journal of Biological Chemistry.

[64]  D. Richardson,et al.  Potent iron chelators increase the mRNA levels of the universal cyclin-dependent kinase inhibitor p21(CIP1/WAF1), but paradoxically inhibit its translation: a potential mechanism of cell cycle dysregulation. , 2003, Carcinogenesis.

[65]  M. Sznol,et al.  Phase I and pharmacokinetic study of the ribonucleotide reductase inhibitor, 3-aminopyridine-2-carboxaldehyde thiosemicarbazone, administered by 96-hour intravenous continuous infusion. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[66]  G. Rodgers,et al.  Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. , 1990, Blood.

[67]  C. Rinker-Schaeffer,et al.  What defines a useful marker of metastasis in human cancer? , 1999, Journal of the National Cancer Institute.

[68]  F. Larcher,et al.  Regulation of the differentiation‐related gene Drg‐1 during mouse skin carcinogenesis , 2001, Molecular carcinogenesis.

[69]  C. Cordon-Cardo,et al.  Drg1 Expression in 131 Colorectal Liver Metastases: Correlation with Clinical Variables and Patient Outcomes , 2005, Clinical Cancer Research.

[70]  T. Shuin,et al.  Downregulation of Cap43 gene by von Hippel‐Lindau tumor suppressor protein in human renal cancer cells , 2003, International journal of cancer.

[71]  Ken Saito,et al.  Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression , 2004, Oncogene.

[72]  Huajian Gao,et al.  A microarray-based gastric carcinoma prewarning system. , 2005, World journal of gastroenterology.

[73]  T. Chao,et al.  Regulatory mechanisms controlling human E-cadherin gene expression , 2005, Oncogene.

[74]  D. Richardson.  Iron chelators as therapeutic agents for the treatment of cancer. , 2002, Critical reviews in oncology/hematology.

[75]  Hakan Cangul,et al.  Hypoxia upregulates the expression of the NDRG1 gene leading to its overexpression in various human cancers , 2004, BMC Genetics.

[76]  D. Richardson,et al.  Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. , 2004, Blood.

[77]  H. Yee,et al.  Enhanced Expression of a Novel Protein in Human Cancer Cells: A Potential Aid to Cancer Diagnosis , 2004, Cell Biology and Toxicology.

[78]  W. Dinjens,et al.  A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[79]  C. Cordon-Cardo,et al.  A Phase I Clinical Trial of the Sequential Combination of Irinotecan Followed by Flavopiridol , 2005, Clinical Cancer Research.

[80]  K. Miura,et al.  Advances in Brief PTEN UpRegulates the Tumor Metastasis Suppressor Gene Drg-1 in Prostate and Breast Cancer , 2004 .

[81]  A. Sartorelli,et al.  Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity. , 2000, Biochemical pharmacology.

[82]  L. Kretzner,et al.  The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc , 2003, Molecular and Cellular Biochemistry.

[83]  P. Ongusaha,et al.  Function of Drg1/Rit42 in p53-dependent Mitotic Spindle Checkpoint* , 2004, Journal of Biological Chemistry.

[84]  A. Steinmetz,et al.  A transmitting tissue- and pollen-expressed protein from sunflower with sequence similarity to the human RTP protein , 1997 .

[85]  M. Blagosklonny,et al.  The Regulation of Hypoxic Genes by Calcium Involves c-Jun/AP-1, Which Cooperates with Hypoxia-Inducible Factor 1 in Response to Hypoxia , 2002, Molecular and Cellular Biology.